Biomatrix develops minimally invasive biomaterial to treat intervertebral disc degeneration

Alan Condon -   Print  |

NC Biomatrix BV is producing a biomaterial that will assist the treatment of intervertebral disc degeneration in a minimally invasive way, reports Innovation Origins.

Three insights:

1. The biomaterial is a cell-driven matrix gel that can be injected into the spinal disc and repair disc volume and height, which would ease pain in patients suffering from degenerative disc disease.

2. It will also offer a scaffold for autologous cellular regeneration of the disc core.

3. The biomaterial contains swelling properties which allow it to soak up fluid and expand, rejuvenating the pressure inside the disc to achieve the same height pre-degeneration.

More articles on biologics:
Biomaterials startup raises $500K for scaffolds to treat spinal cord injuries
Dr. Robert LaPrade on the biggest thing to hit sports medicine since the arthroscope
Ossio wins Frost & Sullivan award for bone regeneration technology — 4 insights

© Copyright ASC COMMUNICATIONS 2021. Interested in LINKING to or REPRINTING this content? View our policies here.

Featured Webinars

Featured Whitepapers